Cathryn Lewis

@cathrynlewis.bsky.social

Genetics - Statistics - Psychiatry. Depression pharmacogenetics. SGDP Centre, King’s College London. Psychiatric Genomics Consortium.

(1/2) Only one-third of people taking antidepressants for depression respond to the first drug they are prescribed and we know little about WHICH drug will work for each patient.

Psychiatric Genomics Consortium (PGC)@pgcgenetics.bsky.social · last yr.

Day 4 of the 2nd Week of #MDD & #Anxiety takeover! How do genetic differences shape individual responses to treatment?This is what recent research has begun to investigate.. 💊

Women make up only 16% of corresponding authors who submit to Nature, a new Springer Nature analysis revealed. This is not enough - there are 30-40% #womeninSTEM We want to change it, through targeted editorial policies & outreach. But change will take everyone! 🧪 www.nature.com/articles/d41...

Gender equality in research publishing is a responsibility for everyone

A concerted effort is needed to support women in their choice of journal when submitting their manuscript.

nature.com

"This work is a first step in using health records to define and predict SSRI drug responses." - Professor Cathryn Lewis @cathrynlewis.bsky.social is Deputy Lead of our Trials, Genomics and Prediction theme, and the research was supported by @nihr.bsky.social and @wellcometrust.bsky.social 👇

Institute of Psychiatry, Psychology & Neuroscience@kingsioppn.bsky.social · last yr.

Who benefits from antidepressants? New research from IoPPN ( @cathrynlewis.bsky.social) and University of Edinburgh shows how measuring antidepressant ‘switching can help scientists and clinicians understand why antidepressants work for some people and not for others www.kcl.ac.uk/news/who-ben...

Our new paper assessing switching between antidepressants as a measure of non-response is now out in BPGOS. Genetic studies show prediction from polygenic scores of remission from clinical studies. Paper: www.sciencedirect.com/science/arti... @kingsioppn.bsky.social Webstory ⬇️

Antidepressant Switching as a Proxy Phenotype for Drug Nonresponse: Investigating Clinical, Demographic, and Genetic Characteristics

Selective serotonin reuptake inhibitors (SSRIs) are a first-line pharmacological therapy in major depressive disorder (MDD), but treatment response ra…

sciencedirect.com

Institute of Psychiatry, Psychology & Neuroscience@kingsioppn.bsky.social · last yr.

Who benefits from antidepressants? New research from IoPPN ( @cathrynlewis.bsky.social) and University of Edinburgh shows how measuring antidepressant ‘switching can help scientists and clinicians understand why antidepressants work for some people and not for others www.kcl.ac.uk/news/who-ben...

Paper published: first output from our Wellcome Trust Mental Health Award, AMBER, on how UK Biobank participants report on whether antidepressants helped their depression. tl;dr 75% said SSRI antidepressants helped them feel better ➡️ Paper in Psychological Medicine bit.ly/4ifjcWC 🧵

Bild

The Ripke lab has worked on a new stable release of RICOPILI! Updates include compatibility with GRCh38 and imputation using Minimac4. A software tarball and YAML file are provided to help resolve dependency issues: github.com/Ripkelab/ric... Any feedback is highly welcome! @pgcgenetics.bsky.social

GitHub - Ripkelab/ricopili: Main ricopili repo for public releases

Main ricopili repo for public releases. Contribute to Ripkelab/ricopili development by creating an account on GitHub.

github.com